Benjamin Cravatt
Director/Board Member bij FIBROGEN, INC.
Vermogen: 67 530 $ op 31-03-2024
Profiel
Benjamin F.
Cravatt is the founder of ActivX Biosciences, Inc. (founded in 2000), Abide Therapeutics, Inc. (founded in 2011), Vividion Therapeutics, Inc. (founded in 2014), Belharra Therapeutics, Inc. (founded in 2021), and Boundless Bio, Inc. (founded in 2018).
Dr. Cravatt is also the founder of Kisbee Therapeutics, Inc., Kojin Therapeutics, Inc., Magnet Biomedicine, Inc...
Dr. Cravatt's current job(s) include being an Independent Director at FibroGen, Inc. since 2020, a Director at Inception Sciences, Inc., a Director at Sea Pharmaceuticals LLC since 2019, a Director at Autobahn Therapeutics, Inc. since 2020, and a Member of the National Academy of Sciences, American Academy of Arts & Sciences, National Academy of Medicine (United States), and National Academy of Inventors.
Dr. Cravatt's former job(s) include being a Professor at The Scripps Research Institute and an Advisor at 5AM Venture Management LLC in 2010.
Dr. Cravatt's education history includes an undergraduate degree from Stanford University and a doctorate from The Scripps Research Institute in 1996.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
FIBROGEN, INC.
0.03% | 09-06-2023 | 28 736 ( 0.03% ) | 67 530 $ | 31-03-2024 |
Actieve functies van Benjamin Cravatt
| Bedrijven | Functie | Begin |
|---|---|---|
| FIBROGEN, INC. | Director/Board Member | 05-08-2020 |
Autobahn Therapeutics, Inc.
 Autobahn Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Autobahn Therapeutics, Inc. is a thyromimetics drug discovery company. It serves patients with neurodegenerative disorders. The company is headquartered in San Diego, CA. | Director/Board Member | 09-06-2020 |
Belharra Therapeutics, Inc.
 Belharra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker. | Founder | 01-01-2021 |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Director/Board Member | - |
National Academy of Inventors
 National Academy of Inventors Miscellaneous Commercial ServicesCommercial Services The National Academy of Inventors operates as a business association that promotes investors. The private company is based in Tampa. | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Corporate Officer/Principal | - |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Inception Sciences, Inc. provides small molecule pharmaceutical incubator services. Its focus is on creating therapies with transformative potential to address diseases and disorders. The company creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded in 2011 and is headquartered in San Diego, CA. | Director/Board Member | - |
Sea Pharmaceuticals LLC
 Sea Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sea Pharmaceuticals LLC manufactures and markets pharmaceutical products and services. The company is headquartered in Cambridge, MA. | Director/Board Member | 01-06-2019 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Eerdere bekende functies van Benjamin Cravatt
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Opleiding van Benjamin Cravatt
| Stanford University | Undergraduate Degree |
| The Scripps Research Institute | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Bedrijven in privébezit | 15 |
|---|---|
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Health Technology |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA | Health Technology |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Commercial Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Inception Sciences, Inc. provides small molecule pharmaceutical incubator services. Its focus is on creating therapies with transformative potential to address diseases and disorders. The company creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded in 2011 and is headquartered in San Diego, CA. | Health Technology |
Sea Pharmaceuticals LLC
Sea Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sea Pharmaceuticals LLC manufactures and markets pharmaceutical products and services. The company is headquartered in Cambridge, MA. | Health Technology |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Commercial Services |
National Academy of Inventors
National Academy of Inventors Miscellaneous Commercial ServicesCommercial Services The National Academy of Inventors operates as a business association that promotes investors. The private company is based in Tampa. | Commercial Services |
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Autobahn Therapeutics, Inc. is a thyromimetics drug discovery company. It serves patients with neurodegenerative disorders. The company is headquartered in San Diego, CA. | Commercial Services |
Kisbee Therapeutics, Inc.
 Kisbee Therapeutics, Inc. BiotechnologyHealth Technology Kisbee Therapeutics, Inc develops novel therapeutic agents for neurodegenerative diseases. The company was founded by Benjamin Cravatt, Jennifer Lippincott Schwartz, Emily Ricqu and Stuart L.Schreiber and is headquartered in DE. | Health Technology |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
Magnet Biomedicine, Inc.
 Magnet Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Magnet Biomedicine, Inc. is a biotechnology company based in Cambridge, MA. Magnet Biomedicine is advancing molecular glue discovery with rational selection and design through their TrueGlue discovery platform. The company applies cutting-edge advancements in human biology and proteomics to identify fit-for-purpose glues that maximize therapeutic impact and offer prominent benefits such as improving selectivity, inducing biological synergy on defined targets, and addressing historically undruggable proteins. Magnet Biomedicine is revolutionizing human medicine with molecular glues and is tackling multiple disease areas and biological mechanisms, including cancer, cardiovascular disease, and immune disorders. The company was founded by Benjamin F. Cravatt, Stuart L. Schreiber, Michael Rosbash, Richa Saxena. | Commercial Services |
Belharra Therapeutics, Inc.
Belharra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker. | Health Services |
